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Background: Dioscorea bulbifera is an African medicinal plant used to treat microbial infections. In the present
study, the methanol extract, fractions (DBB1 and DBB2) and six compounds isolated from the bulbils of D. bulbifera,
namely bafoudiosbulbins A (1), B (2), C (3), F (4), G (5) and 2,7-dihydroxy-4-methoxyphenanthrene (6), were tested
for their antimicrobial activities against Mycobacteria and Gram-negative bacteria involving multidrug resistant
(MDR) phenotypes expressing active efflux pumps.
Methods: The microplate alamar blue assay (MABA) and the broth microdilution methods were used to determine
the minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) of the above samples.
Results: The results of the MIC determinations indicated that when tested alone, the crude extract, fractions DBB1
and DBB2 as well as compounds 2 to 5 were able to prevent the growth of all the fifteen studied microorganisms,
within the concentration range of 8 to 256 μg/mL. The lowest MIC value for the methanol extract and fractions
(16 μg/mL) was obtained with DBB1 and DBB2 on E, coli AG100A and DBB2 on Mycobacterium tuberculosis MTCS2.
The lowest value for individual compounds (8 μg/mL) was recorded with compound 3 on M. smegmatis and M.
tuberculosis ATCC and MTCS2 strains respectively. The activity of the samples on many MDR bacteria such as
Enterobacter aerogenes EA289, CM64, Klebsiella pneumoniae KP63 and Pseudomonas aeruginosa PA124 was better
than that of chloramphenicol. When tested in the presence of the efflux pump inhibitor against MDR
Gram-negative bacteria, the activity of most of the samples increased. MBC values not greater than 512 μg/mL
were recorded on all studied microorganisms with fraction DBB2 and compounds 2 to 5.
Conclusions: The overall results of the present investigation provided evidence that the crude extract D. bulbifera
as well as some of the compounds and mostly compounds 3 could be considered as potential antimicrobial drugs
to fight against MDR bacteria.
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The continuous emergence of Gram-negative MDR bac-
teria drastically reduces the efficacy of our antibiotic ar-
mory and, consequently, increases the frequency of
therapeutic failure [1]. On the other hand, the World
Health Organization (WHO) estimates that there are
nine million cases of tuberculosis (TB) currently, with
1.3 million reported deaths every year, 55 and 30% of the* Correspondence: Kuetevictor@yahoo.fr; tapondjou2001@yahoo.fr
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reproduction in any medium, provided the orTB burden being shared by Asian and African countries re-
spectively [2]. Approximately 60% of world’s population still
relies on medicinal plants for their primary healthcare.
Medicinal plants have been used as a source of remedies
since ancient times in Africa. Dioscorea bulbifera L. var
sativa (Dioscoreaceae) is an African medicinal plant used
to treat microbial infections and pig cysticercosis by the na-
tive people of western highlands of Cameroon. The plant is
also used as a folk remedy to treat conjunctivitis, diarrhea
and dysentery, among other ailments [3]. Previous phyto-
chemical study on this medicinal plant led to the isolation
and structural elucidation of seven new clerodane diterpe-
noids namely Bafoudiosbulbins A-G [4-6]. Furthermore,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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possess anti-Salmonella activity [4]. In the present study,
the bioguided fractionation was undertaken in order to
deeply evaluate the antimicrobial activity of D. bulbifera.
Methods
Plant material
The bulbils of D. bulbifera L. var sativa were collected
in Bafou village near Dschang (West region of Cameroon)
in February 2007. The plant was identified at the
National Herbarium (Yaoundé, Cameroon) where a vou-
cher specimen was deposited under the reference number
22211/SRF/CAM.
Extraction and isolation
The air-dried bulbils of D. bulbifera L. var sativa (2 kg)
were pulverized and extracted three times (each time for
24 h) with MeOH. The methanol extract was concen-
trated under reduced pressure to yield a dark residue
(DBB; 90 g). Part of this (80 g) was suspended in water
(150 mL) and submitted to successive partition with Ethyl
acetate (EtOAc) and n-butanol. The EtOAc and n-butanol
layers were concentrated to dryness under reduced pres-
sure to afford 35 g and 23 g of extracts respectively. The
n-butanol extract showed no antimicrobial activity con-
trary to the EtOAc extract (Tables 1 and 2). Part of the
EtOAc extract (DBB1; 28 g) was subjected to column
chromatography over silica gel 60 Merck [0.040–0.063
mm; 56 g] using hexane-EtOAc with increasing polarity
as eluents to yield five main sub-fractions named A-E.
They were then screened for their antimicrobial activities
and sub-Fraction C (DBB2) eluted with Hexane-EtOAc
4–6 to 3–7 was the only active sample. DBB2 (m = 4.8 g)
was then fractionated and purified using column chroma-
tography over silica gel and sephadex LH-20 to yield com-
pound 1 {White needles; [α]D
21 = − 64.6 (c = 0.025,
DMSO); 60 mg; Rf = 0.78, CH2Cl2-MeOH 95–5; C21H22O8
m/z 403 [M+H]+; m.p. = 252-253°C}, compound 2 {White
needles; [α]D
21 = +52 (c = 0.010, pyridine); 71 mg; Rf =
0.44, CH2Cl2-MeOH 95–5; C20H20O8, m/z 387 [M−H]
−; m.
p. = 312-313°C}, compound 3 {White gum; [α]D
21 = +56.2°
(c = 0.8, CH2Cl2); 32 mg; Rf = 0.37, CH2Cl2-MeOH 95–5;
C21H22O7, 358 [M−CO]
+}, compound 4 {White needles; [α]
D
21 = − 5o (c = 0.6, CH2Cl2); 58 mg; Rf = 0.56, CH2Cl2-
MeOH 95–5; C21H24O8; m/z 439 [M+Cl]; m.p. =
265-266°C}, compound 5 {White crystals; [α]D
20 = − 46o
(c = 0.9, CD3OD); 64 mg; Rf = 0.41, CH2Cl2-MeOH 95–5;
C23H26O10; m/z 485 [M+Na]
+; m.p. = 199-200°C},
compound 6 {Yellow amorphous powder; 28 mg; Rf = 0.48,
CH2Cl2-MeOH 95–5; C15H12O3, m/z 241 [M+H]
+}.
General procedure
Melting points were determined using the Gallen-
kampMelting Point Apparatus. Optical rotations weremeasured on a Perkin–Elmer 241 Polarimeter, IR
spectra were measured as a film on a KBr pellet using
a FTIR-8400S Shimadzu spectrometer. ESIMS was car-
ried out on a Hewlett Packard HP-1100 series LC–
MSD system and on the mass spectrometer Brucker
FTMS4.7T, BIOAPEXII. 1H NMR spectra were recorded
in deuterated solvents (DMSO and C5H5N) on a on a
Varian Mercury Plus Spectrometer at 400 MHz while 13C
NMR spectra were recorded in the same solvents and the
same apparatus at 100 MHz. All chemical shifts (δ) are
given in ppm units with reference to tetramethylsilane
(TMS) as internal standard and the coupling constants (J)
are in Hz. Column chromatography was performed using
silica gel 60 Merck (0.040–0.063 mm) and sephadex LH-20.
TLC were carried out on precoated Kieselgel 60 F254
(Merck) plates developed with hexane:AcOEt (7:3)
and AcOEt:MeOH (98:2). TLC plates were viewed
with an ultraviolet lamp MULTIBAND UV-254/365
nm for fluorescent spots. They were also visualized
by spraying with 50% H2SO4 and heating for 10 min
at 110°C.Antimicrobial assays
Chemicals for antimicrobial assay
Chloramphenicol ≥ 98% (Sigma-Aldrich, St. Quentin
Fallavier, France) was used as reference antibiotics (RA)
against Gram-negative bacteria. p-Iodonitrotetrazolium
chloride ≥ 97% (INT, Sigma-Aldrich) was used as micro-
bial growth indicator [8,9]. Ciprofloxacin ≥ 98% and iso-
niazid ≥ 99% (INH) (Sigma) were used as reference
antibiotics (RA) for M. smegmatis and M. tuberculosis re-
spectively. Phenylalanine arginine β-naphthylamide ≥ 98%
(PAßN, Sigma-Aldrich) was used as microbial growth in-
dicator and efflux pumps inhibitor.Microbial strains and culture media
The studied microorganisms included strains of
Pseudomonas aeruginosa, Klebsiella pneumoniae,
Enterobacter aerogenes, Escherichia coli, four Myco-
bacteria namely M. smegmatis, drug-susceptible strain
of M. tuberculosis H37Rv obtained from the American
Type Culture Collection, and two clinical strains of
M. tuberculosis MTCS1, MTCS2. M. smegmatis was
cultured on Middlebrook 7H11 agar and allowed to
grow for 24 h. M. tuberculosis was plated on Löwenstein–
Jensen medium and allowed to grow for 3–4 weeks at 37°C.
Middlebrook 7H9 broth was used to determine the
MIC and MBC values of the test samples on M.
smegmatis and M. tuberculosis. Nutrient agar was
used for the activation of Gram-negative bacteria [10].
The clinical features of the Gram-negative bacteria
are available as Additional file 1.
Table 1 MICs of the extract, fractions, compounds from Dioscorea bulbifera and chloramphenicol on documented strains and clinical MDR isolates
Samplesa Microorganisms and MIC (μg/mL) without and in the presence of PAßN (in parenthesis)b
E. coli E. aerogenes K. pneumoniae P. aeruginosa M.
smegmatis
M. tuberculosis
ATCC8739 AG100A AG102 ATCC13048 EA289 EA-CM64 ATCC11296 KP55 KP63 PA01 PA124 ATCC 700084 ATCC
27294
MTCS1 MTCS2
DBB 64 (64) 64 (32) 128 (128) 64 (64) 256 (128) 256 (256) 64 (64) 128 (128) 128 (128) 128 (128) 128 (128) 64 64 256 64
DBB1 32 (32) 16 (8) 128 (128) 32 (32) 64 (64) 64 (64) 32 (32) 64 (64) 64 (64) 64 (64) 64 (64) 3x2 64 256 32
DBB2 64 (64) 16 (8) 64 (64) 32 (16) 64 (64) 64 (64) 64 (64) 64 (64) 32 (16) 32 (16) 64 (64) 32 32 64 16
1 256 (64) 128 (32) - 256 (128) - (256) - 256 (64) 512 (128) - (256) - (512) - - nd nd nd
2 64 (32) 64 (64) 64 (32) 128 (64) 64 (64) 64 (64) 64 (32) 128 (64) 64 (32) 128 (64) 128 (64) 32 32 32 16
3 64 (16) 16 (8) 64 (16) 64 (16) 64 (16) 64 (16) 64 (32) 64 (16) 64 (32) 128 (32) 128 (32) 8 8 32 8
4 64 (64) 64 (32) 64 (64) 128 (32) 64 (32) 128 (64) 64 (64) 64 (64) 64 (32) 128 (64) 128 (64) 32 64 64 32
5 64 (64) 64 (32) 128 (64) 128 (64) 128 (32) 256 (64) 128 (128) 128 (64) 256 (64) 256 (64) 128 (32) 64 32 64 32
6 256 (256) 256
(256)
- (512) - (512) - (256) - 256 (128) - (256) - (256) - (256) - (512) - nd nd nd
RA 4 (1) 1 (0.5) 16 (1) 4 (1) 512 (128) 256 (8) 2 (2) 32 (4) 512 (128) 128 (8) 256 (8) 0.5 0.5 64 2
aTested samples [DBB: methanol extract from the bulbils of D. bulbifera; bafoudiosbulbins A (1), B (2), C (3), F (4), G (5), 2,7-dihydroxy-4-methoxyphenanthrene (6); EtOAc fraction (DBB1) and EtOAc sub-fraction C
(DBB2); RA : reference antibiotics were chloramphenicol for bacteria, ciprofloxacin for M. smegmatis, isoniazid for M.tuberculosis; (−): MIC > 512 μg/mL; bThe drugs and compounds were tested in the absence or in the
presence (values in braket) of PAßN at a final concentration of 20 μg/mL, as described previously [7]. At this concentration, no intrinsic effect against the various bacterial strains (included as internal controls in each
























Table 2 MBCs of the extract, fractions, compounds from Dioscorea bulbifera and chloramphenicol on documented strains and clinical MDR isolates
Samples Microorganisms and MBC (μg/mL) without and in the presence of PAßN (in parenthesis)*
E. coli E. aerogenes K. pneumoniae P. aeruginosa M.
smegmatis
M. tuberculosis





DBB 128 (128) 128 (64) 256 (256) 128 (128) 512 (512) - (512) 256 (256) 256 (256) 256 (256) 256 (256) 256 (256) 128 128 - 128
DBB1 128 (64) 32 (16) 512 (256) 64 (64) 128 (128) 256 (128) 64 (64) 128 (128) 256 (128) 128 (128) 128 (128) 64 128 - 64
DBB2 256 (128) 32 (16) 256 (128) 64 (32) 128 (128) 256 (128) 128 (128) 128 (128) 64 (64) 64 (64) 256 (128) 128 128 128 64
1 - (256) 256 (128) nd - (256) nd nd - (128) - (256) nd nd nd - nd nd nd
2 128 (128) 128 (64) 128 (128) 256 (128) 128 (128) 128 (128) 128 (128) 256 (128) 128 (128) 512 (128) 256 (128) 64 128 128 64
3 128 (32) 128 (32) 256 (32) 128 (32) 256 (32) 128 (32) 128 (64) 128 (64) 256 (64) 256 (64) 256 (64) 8 16 64 16
4 128 (128) 128 (64) 256 (128) 256 (128) 128 (64) 512 (128) 256 (128) 256 (128) 128 (128) 256 (128) 256 (128) 64 128 128 128
5 128 (128) 128 (128) 256 (128) 256 (128) 256 (128) - (128) 512 (256) 512 (128) - (128) 512 (256) 512 (128) 256 128 256 128
6 - - (512) - nd (−) nd (256) nd - (512) nd (256) nd (256) nd (256) nd (512) - nd nd nd
RA 8 (2) 4 (1) 32 (2) 8 (2) - (256) 512 (16) 4 (4) 64 (8) - (256) 256 (16) 512 (16) 1 1 128 4
aTested samples [DBB: methanol extract from the bulbils of D. bulbifera; bafoudiosbulbins A (1), B (2), C (3), F (4), G (5), 2,7-dihydroxy-4-methoxyphenandhrene (6); EtOAc fraction (DBB1) and EtOAc sub-fraction C
(DBB2); RA : reference andibiotics were chloramphenicol for bacteria, ciprofloxacin for M. smegmatis, isoniazid for M.tuberculosis; (−): MIC > 512 μg/mL; bThe drugs and compounds were tested in the absence or in the
presence (values in braket) of PAßN at a final concendration of 20 μg/mL, as described previously [7]. At this concendration, no indrinsic effect against the various bacterial strains (included as indernal condrols in
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The MIC determinations on M. smegmatis and Gram-
negative bacteria were conducted using rapid INT col-
orimetric assay according to described methods [8,9]
with some modifications. The test samples and RA
were first of all dissolved in DMSO/Mueller Hinton
Broth (MHB) or DMSO/7H9 broth. The final concen-
tration of DMSO was lower than 2.5% and does not
affect the microbial growth [11]. The solution obtained
was then added to 7H9 broth (M. smegmatis) or Mueller
Hinton Broth (Gram-negative organisms), and serially
diluted two fold (in a 96- wells microplate). One hundred
microlitre (100 μL) of inoculum 1.5 x 106 CFU/mL pre-
pared in appropriate broth was then added [12]. The plates
were covered with a sterile plate sealer, then agitated to
mix the contents of the wells using a plate shaker and
incubated at 37°C for 18 h. The assay was repeated thrice.
Wells containing adequate broth, 100 μL of inoculum and
DMSO to a final concentration of 2.5% served as negative
control. The MIC of samples was detected after 18 h incu-
bation at 37°C, following addition (40 μL) of 0.2 mg/mL
p-iodonitrotetrazolium chloride (INT) and incubation at
37°C for 30 min. Viable bacteria reduced the yellow dye
to a pink. MIC was defined as the sample concentration
that prevented the color change of the medium and
exhibited complete inhibition of microbial growth [8,9].
The MBC was determined by adding 50 μL aliquots of
the preparations, which did not show any growth after in-
cubation during MIC assays, to 150 μL of adequate broth.
These preparations were incubated at 37°C for 48 h. The
MBC was regarded as the lowest concentration of extract,
which did not produce a color change after addition of
INT as mentioned above [11,13].
Samples were also tested in the presence of PAßN at
30 μg/mL final concentration [7] and the MIC was
determined as above.
Time-kill dynamic curves against E. coli ATCC8739
Time-kill dynamic assay was performed using broth
microdilution method as previously described [14] with
minor modifications. The final concentration of sus-
pension of the E. coli ATCC8739 strain was adjusted to
106 CFU/mL. The crude extract, fraction DBB2 and
compound 3 were used in the time-kill dynamic experi-
ment. Cells treated with concentrations corresponding
to ½ MIC; MIC and MBC of each sample were incu-
bated at 37°C for 0, 30, 60, 120, 240, 480, and 960 min.
The final concentration of DMSO was 2.5%. A control
sample was made using DMSO 2.5% and the inoculum.
At each incubation time point, liquids (50 μl) were
removed from the test solution for ten-fold serial dilu-
tion. Thereafter, a 25 μl liquid from each dilution was
spread on the surface of the MHA plates and incubated
at 37°C for 24 h, and the number of CFU/mL wascounted. Experiments were carried out in triplicate.
Time-kill curves were constructed by plotting the num-
ber of CFU/mL against time (min).
Microplate Alamar Blue assay against M. tuberculosis
The activity of all samples against M. tuberculosis
strains was tested using the MABA [15]. Briefly, each of
the above M. tuberculosis strains was cultured at 37°C
in Middlebrook 7H9 broth supplemented with 0.2% gly-
cerol and 10% Oleic Acid–Albumin–Dextrose–Catalase
(Sigma) until logarithmic growth was reached. About
6x106 CFU/mL inoculum of M. tuberculosis was then
added to the two fold serially diluted samples. The final
concentration of DMSO in all assays was 2.5% or less
and this dilution also served as solvent control. The
samples were assayed in triplicate. All tests were carried
out in sterile flat bottom 96-well microplates. Each
microplate was incubated for 5 days at 37°C in a sealed
plastic CO2-permeable bag. After 5 days of incubation,
32 μL of a mixture of freshly prepared Alamar Blue
solution and 20% sterile Tween-80 (Sigma) 1:1 v/v were
added to one growth-control well. The microplates
were incubated again at 37°C for 24 h. If a color shift
from blue to pink was observed in the growth-control
sample, 32 μL of alamar blue solution was added to
each of the remaining wells, and the microplate was
further incubated for 24 h. A well-defined pink color
was interpreted as positive bacterial growth, whereas a
blue color indicated an absence of growth. The MIC
corresponded to the greatest dilution of sample
extract in which the color shift from blue to pink was
not observed.
Samples with recorded MIC values following MABA
were assayed for their mycobactericidal effect [15].
Briefly, 5 μL of the undeveloped mycobacterial suspen-
sions were transferred from the former to a new micro-
plate that contained 195 μL of fresh culture medium per
well. Three wells were inoculated with 100 μL of fresh
inoculum as for MABA and three more wells were incu-
bated with 200 μL of culture medium only, as negative
controls. The microplates were incubated and developed
with alamar blue as for MABA. The MBC corre-
sponded to the minimum sample concentration that
did not cause a color shift in cultures re-incubated in
fresh medium.
Results and discussion
The structural elucidation of the isolated compounds
was achieved using physical and spectroscopic techni-
ques as described in our research group. They were
identified as diterpenoids bafoudiosbulbins A (1), B (2)
[4], C (3) [5], F (4), G (5) [6] and 2,7-dihydroxy-4-
methoxyphenanthrene (6) [16]. Their chemical struc-


















































Figure 1 Chemical structures of the compounds isolated from the bulbils of Dioscorea bulbifera.
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tested for their antimicrobial activities and the results
are reported in Tables 1 and 2.
The results of the MIC determinations (Table 1) indi-
cated that when tested alone, the methanol crude extract,
fractions DBB1 and DBB2 as well as compounds 2 to 5
were able to prevent the growth of all the fifteen studied
microorganisms, including mycobacteria and Gram-
negative bacteria, within the concentration range of 8 to
256 μg/mL. Compounds 1 and 6 showed selective activities,
their inhibitory effects being noted respectively on 5/15
(33.3%) and 3/15 (20%) of the studied microorganisms. The
lowest MIC value for the methanol extract and fractions
(16 μg/mL) was obtained with DBB1 and DBB2 on E. coli
AG100A and DBB2 on M. tuberculosis MTCS2. The lowest
value for individual compounds (8 μg/mL) was recorded
with compounds 3 on M. smegmatis and M. tuberculosis
ATCC and MTCS2 strains. The activity of the samples on
many MDR bacteria such as E. aerogenes EA289, CM64,
K. pneumoniae KP63 and P. aeruginosa PA124 was better
than that of chloramphenicol. When tested in the presence
of the efflux pump inhibitor against Gram-negative bacteria
expression active efflux (Table 1), the activity of most of the
samples increased, the lowest MIC values obtained being 8
μg/mL for DBB1 and 2, compound 3 on E. coli AG100A.
Results of MBC determinations (Table 2) also showed good
activities for most of the tested samples. When tested in the
absence of PAßN, MBC values not greater than 512 μg/mLwere recorded on all studied microorganisms with fraction
DBB2, compounds 2 to 5, on 13/15 (86.7%) and 14/15
(93.3%) of the studied organisms respectively the crude ex-
tract and fraction DBB1. As previously observed with MIC
values, compounds 1 and 6 showed poor activities in the
MBC test. Similarly to MICs data, the MBC values of the
samples decrease when they were associated with PAßN.
Also, it can be noted (Figure 1) that significant reduction of
the bacterial population is observed with the crude extract,
fraction DBB2 and compound 3 at a concentration corre-
sponding to their MBC values.
In the present work, broad spectrum of antimicrobial ac-
tivities was recorded with the crude extract, fractions and
compounds from D. bulbifera. Phytochemicals are routinely
classified as antimicrobials on the basis of susceptibility
tests that produce MIC in the range of 100 to 1000 mg/mL
[17]. Activity is considered to be significant if MIC values
are below 100 μg/mL for crude extract and moderate when
100<MIC<625 μg/mL [18,19]. Therefore, the activity
recorded with the crude extract on the ATCC strain of
E. coli, E. aerogenes, K. pneumoniae, M. smegmatis and
M. tuberculosis as well as E. coli AG100A and M. tubercu-
losis MTCS2, can be considered as important. Similarly, the
activity recorded with the two studied fractions from
D. bulbifera on the majority of the studied microbial strains
was also significant. The activity of compound 3 on three
of the four tested mycobacterial strains can also be consid-




























































































Figure 2 Survival curve for E. coli ATCC8739 cells exposed to the crude extract (A), fraction DBB2 (B) and compound 3 (C). (Control):
MHB medium in DMSO 2.5% + inoculum.
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K. pneumoniae KP63 and P. aeruginosa PA124 was
lower than those of the reference drug, highlighting its
good antibacterial potency.
Keen look of the MBC values of the tested samples,
alone or in the presence of the efflux pumps inhibitor
indicates that most of them are not more than fourfold
their corresponding MICs. This proves that the killing
effects of many tested samples could be expected on the
sensitive strains [20]. This can also be confirmed by the
reduction of cell survival at the MBC values of the crude
extract, fraction DBB2 and compound 3 as observed in
Figure 2. Enterobacteriaceae, including K. pneumoniae,
E. aerogenes and E. coli as well as P. aeruginosa and
M. tuberculosis have been classified as antimicrobial-
resistant organisms of concern in healthcare facilities
[21-25]. The good activities of the crude extract, frac-
tions and compound 3 on most of the tested microor-
ganisms belonging to MDR phenotypes such as E. coli
AG102, P. aeruginosa PA124, E. aerogenes CM64,
K. pneumoniae KP55 and KP63 as observed herein rein-
forces the hypothesis that D. bulbifera can be a potential
source of antimicrobial drugs. It should be noted that
active compounds from D. bulbifera are substrates of
MDR bacteria efflux pumps, suggesting a possible use of
an inhibitor in the fight against such strains. In this
work, only compounds with inhibitory activity on
M. smegmatis were tested on M. tuberculosis. However,
it has been demonstrated that the sensitivity of
M. tuberculosis is closer to that of M. smegmatis, a non
pathogenic microorganism [26]. Therefore, this micro-
organism can be used for a preliminary study to select
samples with potential activity against M. tuberculosis
[26]. Hence, the results obtained herein are in accord-
ance with such recommendation.
To the best of our knowledge, the antimicrobial activities
of D. Bulbifera against MDR bacteria and mycobacteria
strain as well as those of the isolated compounds is being
reported for the first time. However the anti-salmonellal
activity of compounds 1 and 2 was reported [4]. Also, anorditerpene, 8-epidiosbulbin E acetate, from Dioscorea
bulbifera was found active against MDR Escherichia coli
and Pseudomonas aeruginosa with MIC values of 200 and
400 μg/mL respectively [27]. The mechanism of the
active compounds is still to be studied; nevertheless,
membrane disruption could be suggested as one of
the likely mechanisms of action of 1 to 5, the compounds
belonging to the terpenoids [28].
Conclusion
The data reported herein are very important, taking in
account the medical importance of the studied micro-
organisms. Hence, the overall results of the present
investigation provided evidence that the crude extract
D. bulbifera as well as some of the compounds, and
mostly compounds 3 could be considered as potential
antimicrobial drug.
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